Financials

  • Market Capitalization 913.81 M
  • Employee 239
  • Founded 2021
  • CEO N/A
  • Website www.alumis.com
  • Headquarter Delaware, United States
  • FIGI BBG01J7X4PN2
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.41
ratio cours/chiffre d'affaires
34.51

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2418
ANRO
Alto Neuroscience, Inc. Common Stock
24.15 USD-0.74%+2.07%-24.53%+318.54%947.70 M USD
2426
KURA
Kura Oncology, Inc. - Common Stock
10.40 USD-1.89%-3.26%-8.53%+6.56%925.19 M USD
2436
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
48.81 USD-0.55%+1.31%+3.15%+62.00%911.76 M USD
2440
MLTX
MoonLake Immunotherapeutics - Class A Ordinary Shares
10.68 USD-1.29%-7.13%-14.97%+11.72%908.94 M USD